MMP9 and triple-A syndrome: Yet, transcript levels of MMP9, a key matrix-degrading enzyme implicated in AAA development33,34, were significantly lower in RNase A- compared to PBS-treated mice, highlighting a potential mechanism by which RNase limits extracellular matrix breakdown.